U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics

The Federal Trade Commission said the deal would enable Amgen to exploit its size to block competition for two expensive Horizon drugs.  » mehr lesen

Similar Articles

Most Popular